Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 2
2007 3
2008 4
2009 3
2013 2
2014 1
2015 2
2016 2
2017 2
2019 1
2020 3
2021 2
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Tau molecular diversity contributes to clinical heterogeneity in Alzheimer's disease.
Dujardin S, Commins C, Lathuiliere A, Beerepoot P, Fernandes AR, Kamath TV, De Los Santos MB, Klickstein N, Corjuc DL, Corjuc BT, Dooley PM, Viode A, Oakley DH, Moore BD, Mullin K, Jean-Gilles D, Clark R, Atchison K, Moore R, Chibnik LB, Tanzi RE, Frosch MP, Serrano-Pozo A, Elwood F, Steen JA, Kennedy ME, Hyman BT. Dujardin S, et al. Among authors: mullin k. Nat Med. 2020 Aug;26(8):1256-1263. doi: 10.1038/s41591-020-0938-9. Epub 2020 Jun 22. Nat Med. 2020. PMID: 32572268 Free PMC article.
PLD3 gene variants and Alzheimer's disease.
Hooli BV, Lill CM, Mullin K, Qiao D, Lange C, Bertram L, Tanzi RE. Hooli BV, et al. Among authors: mullin k. Nature. 2015 Apr 2;520(7545):E7-8. doi: 10.1038/nature14040. Nature. 2015. PMID: 25832413 No abstract available.
Author Correction: Tau molecular diversity contributes to clinical heterogeneity in Alzheimer's disease.
Dujardin S, Commins C, Lathuiliere A, Beerepoot P, Fernandes AR, Kamath TV, De Los Santos MB, Klickstein N, Corjuc DL, Corjuc BT, Dooley PM, Viode A, Oakley DH, Moore BD, Mullin K, Jean-Gilles D, Clark R, Atchison K, Moore R, Chibnik LB, Tanzi RE, Frosch MP, Serrano-Pozo A, Elwood F, Steen JA, Kennedy ME, Hyman BT. Dujardin S, et al. Among authors: mullin k. Nat Med. 2021 Feb;27(2):356. doi: 10.1038/s41591-021-01251-7. Nat Med. 2021. PMID: 33514949 Free PMC article. No abstract available.
Region-based analysis of rare genomic variants in whole-genome sequencing datasets reveal two novel Alzheimer's disease-associated genes: DTNB and DLG2.
Prokopenko D, Lee S, Hecker J, Mullin K, Morgan S, Katsumata Y; Alzheimer’s Disease Neuroimaging Initiative (ADNI); Weiner MW, Fardo DW, Laird N, Bertram L, Hide W, Lange C, Tanzi RE. Prokopenko D, et al. Among authors: mullin k. Mol Psychiatry. 2022 Apr;27(4):1963-1969. doi: 10.1038/s41380-022-01475-0. Epub 2022 Mar 4. Mol Psychiatry. 2022. PMID: 35246634 Free PMC article.
Whole-genome sequencing reveals new Alzheimer's disease-associated rare variants in loci related to synaptic function and neuronal development.
Prokopenko D, Morgan SL, Mullin K, Hofmann O, Chapman B, Kirchner R; Alzheimer's Disease Neuroimaging Initiative (ADNI); Amberkar S, Wohlers I, Lange C, Hide W, Bertram L, Tanzi RE. Prokopenko D, et al. Among authors: mullin k. Alzheimers Dement. 2021 Sep;17(9):1509-1527. doi: 10.1002/alz.12319. Epub 2021 Apr 2. Alzheimers Dement. 2021. PMID: 33797837 Free PMC article.
A comparison between similarity matrices for principal component analysis to assess population stratification in sequenced genetic data sets.
Lee S, Hahn G, Hecker J, Lutz SM, Mullin K; Alzheimer’s Disease Neuroimaging Initiative (ADNI); Hide W, Bertram L, DeMeo DL, Tanzi RE, Lange C, Prokopenko D. Lee S, et al. Among authors: mullin k. Brief Bioinform. 2023 Jan 19;24(1):bbac611. doi: 10.1093/bib/bbac611. Brief Bioinform. 2023. PMID: 36585781 Free PMC article.
28 results